M. Helena Vasconcelos

33.3k total citations · 1 hit paper
164 papers, 6.1k citations indexed

About

M. Helena Vasconcelos is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, M. Helena Vasconcelos has authored 164 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Molecular Biology, 40 papers in Oncology and 30 papers in Pharmacology. Recurrent topics in M. Helena Vasconcelos's work include MicroRNA in disease regulation (20 papers), Extracellular vesicles in disease (19 papers) and Fungal Biology and Applications (17 papers). M. Helena Vasconcelos is often cited by papers focused on MicroRNA in disease regulation (20 papers), Extracellular vesicles in disease (19 papers) and Fungal Biology and Applications (17 papers). M. Helena Vasconcelos collaborates with scholars based in Portugal, Spain and Brazil. M. Helena Vasconcelos's co-authors include Raquel T. Lima, Isabel C.F.R. Ferreira, Emı́lia Sousa, Madalena Pinto, Cristina P. R. Xavier, Anabela Martins, Andreia Palmeira, Josiana A. Vaz, José E. Guimarães and Diana Sousa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

M. Helena Vasconcelos

149 papers receiving 6.0k citations

Hit Papers

The multi-factorial natur... 2019 2026 2021 2023 2019 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Helena Vasconcelos Portugal 40 3.1k 1.3k 1.3k 1.2k 751 164 6.1k
Na Lu China 50 4.3k 1.4× 1.9k 1.4× 1.5k 1.1× 1.4k 1.2× 1.2k 1.6× 199 7.7k
Alok C. Bharti India 39 3.9k 1.3× 734 0.6× 1.5k 1.2× 1.6k 1.4× 409 0.5× 116 7.9k
Jin‐Jian Lu Macao 55 5.6k 1.8× 1.3k 1.0× 1.3k 1.0× 911 0.8× 1.1k 1.5× 237 9.8k
Yasunari Takada United States 39 5.0k 1.6× 982 0.7× 1.5k 1.1× 1.7k 1.4× 567 0.8× 58 9.1k
Xi Zheng China 42 2.9k 0.9× 638 0.5× 561 0.4× 915 0.8× 683 0.9× 203 6.5k
Manoj K. Pandey United States 34 3.1k 1.0× 882 0.7× 1.3k 1.0× 950 0.8× 647 0.9× 79 6.2k
Ya‐Ling Hsu Taiwan 51 4.0k 1.3× 710 0.5× 1.2k 0.9× 1.2k 1.0× 639 0.9× 183 7.1k
Katrin Sak India 37 2.8k 0.9× 705 0.5× 594 0.5× 608 0.5× 729 1.0× 125 5.9k
Santosh K. Sandur India 34 3.1k 1.0× 638 0.5× 858 0.7× 678 0.6× 405 0.5× 88 5.9k
Muthu K. Shanmugam Singapore 62 6.7k 2.1× 930 0.7× 2.5k 2.0× 2.0k 1.7× 744 1.0× 106 11.7k

Countries citing papers authored by M. Helena Vasconcelos

Since Specialization
Citations

This map shows the geographic impact of M. Helena Vasconcelos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Helena Vasconcelos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Helena Vasconcelos more than expected).

Fields of papers citing papers by M. Helena Vasconcelos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Helena Vasconcelos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Helena Vasconcelos. The network helps show where M. Helena Vasconcelos may publish in the future.

Co-authorship network of co-authors of M. Helena Vasconcelos

This figure shows the co-authorship network connecting the top 25 collaborators of M. Helena Vasconcelos. A scholar is included among the top collaborators of M. Helena Vasconcelos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Helena Vasconcelos. M. Helena Vasconcelos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vasconcelos, M. Helena, et al.. (2025). Gastric Volvulus After Nissen Fundoplication: A Case Report. Cureus. 17(11). e97671–e97671.
2.
Vasconcelos, M. Helena, et al.. (2024). Veiled pancreas: Unmasking the riddle of an invisible organ. United European Gastroenterology Journal. 12(4). 526–527. 1 indexed citations
3.
Vasconcelos, M. Helena, et al.. (2024). Infective Endocarditis After Endoscopic Stricture Dilation in Crohn's Disease. ACG Case Reports Journal. 11(6). e01377–e01377.
5.
Côrte‐Real, Leonor, Cristina P. R. Xavier, Xavier Fontrodona, et al.. (2023). Novel family of [RuCp(N,N)(P)]+ compounds with simultaneous anticancer and antibacterial activity: Biological evaluation and solution chemistry studies. European Journal of Medicinal Chemistry. 262. 115922–115922. 3 indexed citations
6.
Magalhães, Ana C., Andreia Palmeira, Diana I. S. P. Resende, et al.. (2023). Evaluation of the Cytotoxic and Antiviral Effects of Small Molecules Selected by In Silico Studies as Inhibitors of SARS-CoV-2 Cell Entry. Molecules. 28(20). 7204–7204. 1 indexed citations
7.
Vasconcelos, M. Helena, et al.. (2023). Repurposing some of the Well-known Non-steroid Anti-inflammatoryDrugs (NSAIDs) for Cancer Treatment. Current Topics in Medicinal Chemistry. 23(13). 1171–1195. 20 indexed citations
8.
Almeida, Nuno, et al.. (2021). Appropriateness of Endoscopic Procedures: A Prospective, Multicenter Study. GE Portuguese Journal of Gastroenterology. 29(1). 5–12. 3 indexed citations
10.
Barbosa, Mélanie A. G., Cristina P. R. Xavier, Rúben F. Pereira, Vilma Petrikaitė, & M. Helena Vasconcelos. (2021). 3D Cell Culture Models as Recapitulators of the Tumor Microenvironment for the Screening of Anti-Cancer Drugs. Cancers. 14(1). 190–190. 169 indexed citations
11.
Palmeira, Andreia, Emı́lia Sousa, Aylin Köseler, et al.. (2020). Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 Infection. Pharmaceuticals. 13(6). 132–132. 48 indexed citations
12.
Caires, Hugo R., et al.. (2020). Urinary Biomarkers in Bladder Cancer: Where Do We Stand and Potential Role of Extracellular Vesicles. Cancers. 12(6). 1400–1400. 46 indexed citations
13.
Pinto, Vanessa Carla Monteiro, Rui Bergantim, Hugo R. Caires, et al.. (2020). Multiple Myeloma: Available Therapies and Causes of Drug Resistance. Cancers. 12(2). 407–407. 158 indexed citations
14.
Vasconcelos, M. Helena, et al.. (2019). Sigmoid Perforation by a Migrated Plastic Biliary Stent. GE Portuguese Journal of Gastroenterology. 27(3). 215–218. 9 indexed citations
15.
Xavier, Cristina P. R., Milica Pešić, & M. Helena Vasconcelos. (2016). Understanding Cancer Drug Resistance by Developing and Studying Resistant Cell Line Models. Current Cancer Drug Targets. 16(3). 226–237. 32 indexed citations
16.
Portela, Francisco, Paula Lago, José Cotter, et al.. (2016). Anaemia in Patients with Inflammatory Bowel Disease - A Nationwide Cross-Sectional Study. Digestion. 93(3). 214–220. 17 indexed citations
17.
Vizetto‐Duarte, Catarina, Luísa Custódio, Gerardo Acosta, et al.. (2016). Can macroalgae provide promising anti-tumoral compounds? A closer look at Cystoseira tamariscifolia as a source for antioxidant and anti-hepatocarcinoma compounds. PeerJ. 4. e1704–e1704. 32 indexed citations
18.
Ferreira, Isabel C.F.R., Marina Sokóvić, Leo van Griensven, et al.. (2015). Cordyceps militaris (L.) Link Fruiting Body Reduces the Growth of a Non-Small Cell Lung Cancer Cell Line by Increasing Cellular Levels of p53 and p21. Molecules. 20(8). 13927–13940. 19 indexed citations
19.
Teixeira, Maribel, Carlos Maurı́cio Barbosa, Raquel T. Lima, et al.. (2013). Development of noncytotoxic PLGA nanoparticles to improve the effect of a new inhibitor of p53–MDM2 interaction. International Journal of Pharmaceutics. 454(1). 394–402. 17 indexed citations
20.
Palmeira, Andreia, Emı́lia Sousa, Miguel X. Fernandes, Madalena Pinto, & M. Helena Vasconcelos. (2011). Multidrug Resistance Reversal Effects of Aminated Thioxanthones and Interaction with Cytochrome P450 3A4. Journal of Pharmacy & Pharmaceutical Sciences. 15(1). 31–31. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026